NEW YORK, September 18, 2012—Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, is pleased to announce that it will present three papers at the upcoming EphMRA Asia Pharmaceutical Market Research Conference, including two with clients. The papers, which reflect the conference theme “Turning Challenge into Opportunity,” are as follows:
Japanese market and patient-level insights – uncovering unmet needs and identifying trends and comparisons with habits and attitudes (Wednesday, September 26, 11:10 am): Delivered by Graeme Jacombs, Kantar Health Managing Director, APMEA, and Merck KK’s Kenneth Shearer, who heads up market research in their Customer Commercial Excellence Division, this presentation will cover how unmet needs in Japan compare with the key G8 markets and how epidemiology and outcomes insights can inform strategic portfolio planning.
Achieving innovation through appropriate online stakeholder communication (Wednesday, September 26, 1:20 pm): Simon Li, General Manager, Kantar Health China, and Dr. Nadja Christe, Healthcare Professional Digital Marketing Manager, Bayer Pharma AG, will discuss how the latest online segmentation techniques have been used at Bayer to ensure maximum stakeholder engagement. They will also highlight the differences in how doctors consume information in the East (namely China) and the West.
Understanding market access drivers for oncology therapies in Asia (Thursday, September 27, 9:30 am): Questa Lin, Country Manager, Kantar Health Taiwan, will present on reimbursement differences across three key Asian markets – China, Taiwan and South Korea – and outline oncology market access hurdles and opportunities in these countries.
Visitors to Kantar Health’s stand can also gain an understanding of their own digital type by answering questions on their lifestyle and online consumption.
About Kantar Health (www.kantarhealth.com)
Kantar Health is a global, evidence-based decision support partner to the world’s leading pharmaceutical, biotech, device and diagnostic companies. Our 700+ staff act as catalysts, working closely with customers to drive distinctive decision-making that helps them prioritize product development and portfolios, differentiate their brands and ensure product profitability after launch. We are unique in that we bring together clinical, medical and methodological expertise, commercial/marketing know-how and proprietary data. It is this rare combination, together with our unparalleled stakeholder reach, that enables us to mobilize incisive, imaginative and timely ROI-driven solutions, empowering clients to deliver better healthcare options to their customers.
With staff in over 40 countries, we excel at solving technically or logistically challenging projects around the world and across the product lifecycle, combining on-the-ground know-how and global and national proprietary data to quickly identify value drivers. As part of WPP, we can also incorporate highly innovative thinking from outside the industry into our solutions.
For more information on Kantar Health, please contact Monica Hart, Vice President, Global Marketing, at firstname.lastname@example.org or +44 (0)75077 80904.